At LifeX, the world's leading minds come together to solve our biggest health problems.
The revolutionary solutions we develop have the potential to alleviate mass suffering and death on a global scale.
HEALTHCARE HAS TO CHANGE, BECAUSE IF WE FAIL TO ACT...
Over half of adults currently under 65 will be diagnosed with cancer1
By 2050, resistance to antibiotics will kill more people than cancer2
65 million more adults in the US will be obese by 20303
IT'S OUR MISSION TO SIGNIFICANTLY REDUCE THE GLOBAL DISEASE BURDEN
Complex illnesses are putting an unprecedented strain on healthcare systems that are already stretched. At LifeX, we believe we can change this.
Where others might see issues that are just too vast and too difficult, we see solvable problems.
SUCCESS WILL BE MEASURED IN THE NUMBER OF LIVES WE IMPROVE, NOT ONLY THE AMOUNT OF MONEY WE MAKE.
Dr. Dietrich Stephan Ph.D., LifeX CEO and Founder
LifeX is made up of three complementary ventures:
THE LABS ARE OUR HOME
We chose our home in Pittsburgh, but the impact of what we do here is felt around the globe. LifeX Labs is a high-tech facility that’s nurturing the next generation of biotech companies.
BIG IS BEAUTIFUL
The Capital Funds provide financing to transform concepts with promise into high-impact companies with world class talent. The opportunities range from early stage investment with the Seed Fund to at-scale financing with the Growth Fund.
STORIES OF SUCCESS
Companies in the LifeX Portfolio have two things in common: stand out innovation and billion-dollar potential. This trail-blazing, transformational group have been funded or facilitated by LifeX.
LifeX represents a one-of-a-kind opportunity. It’s about realizing potential, securing investment and making a tangible difference to global health.
We’re building a forward-thinking portfolio, with first-in-class solutions and the potential to help millions of people and earn significant financial returns.
The University of Pittsburgh and its Graduate School of Public Health are founding partners of LifeX - investing in the future for those who are suffering and dying needlessly.
1. Ahmad AS et al. Brit J Cancer 2015; 112: 943–947. 2.The Review on Antimicrobial Resistance 2016 https://amr-review.org Accessed April 2018. 3. 'Half of UK obese by 2030' https://www.nhs.uk/news/obesity/half-of-uk-obese-by-2030/ Accessed April 2018.